-
Most Recent
Cannabis Stocks
Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.
3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030
These are the cannabis stocks to buy as they represent companies with improving fundamentals and accelerated growth outlook.
7 Growth Stocks That Could 7X in the Next 7 Years
Investors consider these growth stocks to buy since they represent companies with good fundamentals and a positive industry outlook.
3 Cannabis Stocks to Sell in August Before They Crash & Burn
Marijuana could be a major industry in the U.S. if it was legalized but these cannabis stocks to sell have other problems to contend with.
Other industries you might be interested in
Recent Cannabis Stocks Articles
I’m Recommending Canopy Growth Stock… but Not for the Reason You Think
Owning CGC stock is a legalized-cannabis play, of course – but could it also be a sports-nutrition play?
Will Federal Legalization Occur in Time to Save Aurora Cannabis Stock?
ACB stock needs enough cash to reach 2021, when the market for recreational marijuana may open wider in the U.S.
Don’t Expect a Sharp Reversal in Aurora Cannabis Stock
Investors should expect medicinal cannabis growth to slow, extending the cash burn of ACB stock. For now, long-term investors should avoid it.
Why Investors Should Continue to Avoid Cronos Stock
Long-term upside in CRON stock is compelling, but the bull thesis lacks conviction and clarity at the current moment.
What Canopy Growth Stock Needs to Rally
CGC stock is in decline, touching an 18-month low this week. The pressure on Canopy Growth stock will continue until the company responds.
Should Contrarian Investors Buy Aurora Cannabis Stock in October?
ACB stock's struggle with profitability reflects the overall headwinds faced by the entire cannabis industry.
Cannabis Stocks: Be Ready for the Next Catalyst
A new bill making its way through Congress is set to upend this outdated legal regime and usher in the next wave of growth in cannabis stocks.
Cannabis Stocks: We’ve Collected our First Cannabis Cash!
Matt McCall's strategy harnesses the growth of cannabis stocks and combines it with the income available from covered calls.
The Tables Could Soon Turn Back in Favor of Tilray Stock
Tilray stock has been beaten to a pulp, like most other pot stocks. But, there's a nuance here that could readily reignite TLRY shares.
VIDEO: Invest in Emerging Markets Stocks to Balance Your Portfolio
Invest in emerging markets stocks to balance your portfolio and position yourself for long-term growth. Tune into "Moneyline" for more.
Marijuana Stocks: How to Profit Twice
Use this proven strategy to boost your returns in an absolutely massive investing theme: marijuana legalization.
Aurora Cannabis Has Become a ‘Blood in the Streets’ Opportunity
Aurora Cannabis (ACB) stock has continously overpromised and underdelievered, but 'Cannabis 2.0' could be a major turning point for ACB stock holders.
Canopy Growth Emerges as Top ‘Cannabis 2.0’ Stock
Canopy Growth stock is down from its previous highs, but CGC stock is well-positioned for the next leg of cannabis trends.
3 Marijuana Stocks Better Than Aurora Cannabis
Popular marijuana stocks like Aurora have taken a beating in recent months as market enthusiasm has died down and reality has set in about growth and regulatory challenges. Today, the best cannabis plays may be under-the-radar stocks.
Will Cannabis 2.0 Save Canopy Growth Stock?
Will Cannabis 2.0 be enough to save CGC? The management of the company believes that it will be a major catalyst for CGC stock
It’s Finally Time to Consider Buying Canopy Growth Stock
After initially recommending investors stay on the sidelines with CGC, evidence is building that they should now consider purchasing shares.
Cronos Group Stock May Get Boost From Cannabinoid Production
Cronos may have an advantage in cannabinoid production, due to a strategic partnership. That could help CRON stock.
The Correction Is a Solid Opportunity to Buy Hexo Stock
Earlier in the year, you would've needed a good psychiatrist if you purchased HEXO stock at its lofty levels. But now? Hexo is ripe for the picking.
